|
|
|
||||||||||
Undergraduate Student, Duke University, Durham, NC
Statistician, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, Durham
Professor, Department of Medicine, Division of General Internal Medicine, Duke University; Director, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center
Associate Research Professor, Department of Medicine, Division of General Internal Medicine; Department of Psychiatry and Behavioral Sciences, and Center for Aging and Human Development, Duke University; Associate Director, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center
Reprints: Dr. Bosworth, Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center (152), 508 Fulton St., Durham, NC 27705-3875, fax 919/416-5836, hboswort{at}acpub.duke.edu
BACKGROUND: Hypertension is poorly controlled in the US due to medication nonadherence. Recent evidence suggests that nonadherence can be classified as intentional or unintentional and different patient characteristics, such as the experience of adverse effects, may be associated with each.
OBJECTIVE: To examine associations between patient characteristics, including reported adverse effects, and both intentional and unintentional nonadherence among 588 hypertensive patients.
METHODS: Baseline data from a clinical trial, the Veterans' Study To Improve the Control of Hypertension, were examined. Intentional and unintentional nonadherence were assessed using a self-report measure. Participants were presented with a list of adverse effects commonly associated with antihypertensive medication and asked to indicate which symptoms they had experienced. Logistic regression analyses were used to examine adjusted associations between patient characteristics and type of nonadherence.
RESULTS: Approximately 31% of patients reported unintentional
nonadherence and 9% reported intentional nonadherence. Non-white participants,
individuals without diabetes mellitus, and individuals reporting
5 adverse
effects were more likely to report intentional nonadherence than their
counterparts. Individuals with less than a 10th-grade education and non-white
participants were more likely to report unintentional nonadherence than their
counterparts. When symptoms of increased urination and wheezing/shortness of
breath were reported, patients were more likely to report intentional and
unintentional nonadherence compared with those who were adherent.
Unintentional nonadherence was also associated with reports of dizziness and
rapid pulse.
CONCLUSIONS: Both intentional and unintentional nonadherence are common and related to perceived adverse effects. Furthermore, different interventions may be necessary to improve adherence in unintentionally and intentionally nonadherent patients.
Key Words: adverse effects, hypertension, treatment adherence
Published Online, June 14, 2005. www.theannals.com, DOI 10.1345/aph.1E594
This article has been cited by other articles:
![]() |
A. J. Mitchell and T. Selmes Why don't patients take their medicine? Reasons and solutions in psychiatry Advan. Psychiatr. Treat., September 1, 2007; 13(5): 336 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.S. Leslie, C.R. Hankey, and M.E.J. Lean Weight gain as an adverse effect of some commonly prescribed drugs: a systematic review QJM, July 1, 2007; 100(7): 395 - 404. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. George, K. Munro, D. J McCaig, and D. C Stewart Prescription Medications: Beliefs, Experiences, Behavior, and Adherence of Sheltered Housing Residents Ann. Pharmacother., December 1, 2006; 40(12): 2123 - 2129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Halpern, Z. M. Khan, J. K. Schmier, M. Burnier, J. J. Caro, J. Cramer, W. L. Daley, J. Gurwitz, and N. K. Hollenberg Recommendations for Evaluating Compliance and Persistence With Hypertension Therapy Using Retrospective Data Hypertension, June 1, 2006; 47(6): 1039 - 1048. [Full Text] [PDF] |
||||
![]() |
M. Malone Medications Associated with Weight Gain Ann. Pharmacother., December 1, 2005; 39(12): 2046 - 2054. [Abstract] [Full Text] [PDF] |
||||